Otsuka Beijing Research Institute clinical trials

A country office of Otsuka Holdings Co., Ltd.

The registry lists 36 studies whose lead sponsor is Otsuka Beijing Research Institute. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 16, 2026.

Studies

Recruiting first, then most recently updated. Showing 36 of 36. All Otsuka Holdings Co., Ltd. studies →

• PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic SyndromesActive, not recruitingNCT06091267Phase 1/2

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I MutationCompletedNCT04233346Phase 2

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• a Phase I PK Study in Healthy Male Subjects. 2 Groups of Healthy Male SubjectsCompletedNCT07166796Phase 1

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial ProtocolCompletedNCT07166783Phase 1

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Phase I Study Multi Dose of 7.5mg Tolvaptan in Health MaleCompletedNCT07166887Phase 1

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With ADCompletedNCT05667623Phase 3

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Safety and Tolerability, and PK of Sibeprenlimab in Chinese Healthy SubjectCompletedNCT07105124Phase 1

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Safety and Efficacy of Brexpiprazole in the Treatment of SchizophreniaCompletedNCT03874494Phase 3

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple MyelomaCompletedNCT00511082Phase 1

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea TypeCompletedNCT05923892Phase 2

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese SubjectsCompletedNCT05583474Phase 3

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia SubjectCompletedNCT02098460Phase 4

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related BiomarkerCompletedNCT00823849Phase 4

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients with ADCompletedNCT05650320Phase 3

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• A Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute HyponatremiaCompletedNCT00664014Phase 2

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy SubjectsCompletedNCT03734302Phase 1

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Efficacy and Safety Study of Aripiprazole to Treat SchizophreniaCompletedNCT00202007Phase 2

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• The Pharmacokinetics, Tolerability and Safety of Brexpiprazole in Healthy Chinese SubjectsCompletedNCT03734354Phase 1

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• OPC-61815 in Healthy Chinese Male SubjectsCompletedNCT05439148Phase 1

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic DisorderCompletedNCT03487770Phase 3

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's SyndromeCompletedNCT03487783Phase 3

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Aripiprazole IM Depot in the Acute Treatment of Adults With SchizophreniaCompletedNCT03172871Phase 3

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Aripiprazole IM Depot for Chinese Patients With SchizophreniaCompletedNCT03287505Phase 1

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive DisorderTerminatedNCT03487198Phase 3

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• PK Study of Aripiprazole IM Depot for Chinese Patients With SchizophreniaCompletedNCT03285503Phase 1

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• A Bioequivalence Study Comparing a Single Oral Intake of an Imported PROBUCOL Tablet(Lorelco) With a Marketed PROBUCOL Tablet(Chang Tai) in Chinese Healthy VolunteersCompletedNCT02196805Not applicable

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Phase 1, Dose-escalation Trial of OPB-51602 in Patients With Advanced Solid TumorsCompletedNCT01184807Phase 1

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac EdemaCompletedNCT01651156Phase 3

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male SubjectsCompletedNCT01590901Phase 1

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Efficacy and Safety of Imported Probucol to Treat HyperlipidemiaCompletedNCT01349010Phase 3

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic NephropathyCompletedNCT01252056Phase 4

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Phase III Study of Tolvaptan Tablet to Treat Cirrhosis AscitesCompletedNCT01349348Phase 3

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With AscitesCompletedNCT01349335Phase 2

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With HepatocirrhosisCompletedNCT01359462Phase 1

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study SubjectCompletedNCT00823875Phase 4

  Sponsor listed in the registry: Otsuka Beijing Research Institute

• Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of StrokeCompletedNCT00202020Phase 3

  Sponsor listed in the registry: Otsuka Beijing Research Institute